Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study
Table 1
Sociodemographic and clinical characteristics of the patients prior to the beginning of insulin pump therapy.
Feature
Measure
Age, SD
Gender, (%)
Female
33 (64.71)
Male
18 (35.29)
Socioeconomic stratum, (%)
1–2 (low)
25 (49)
3–4 (middle)
17 (33.3)
5–6 (high)
9 (17.6)
Educational level, (%)
Elementary school
1 (1.96)
High school
10 (19.61)
Technician/technologist
12 (23.53)
Professional
18 (35.29)
Specialization/master´s
10 (19.61)
Type of diabetes, (%)
Type 1
46 (90.2)
Type 2
3 (5.9)
Other
2 (3.9)
Time since diagnosis of diabetes (months)
197 (100-336)
Weight (kg)
63.2 (56.9-69.5)
Height (cm)
161.5 (148-166.5)
BMI
24 (22.39-26.1)
Total daily insulin dose (IU)
39 (30-60)
HbA1c (%)
8.21 (7.2-9.13)
Indication to start insulin pump therapy, (%)
Hypoglycemia
11 (21.6)
High variability
9 (17.6)
Poor metabolic control
7 (13.7)
Hypoglycemia and high variability
9 (17.6)
Hypoglycemia and poor metabolic control
9 (17.6)
Poor metabolic control and high variability
3 (5.9)
Hypoglycemia, poor metabolic control and high variability
3 (5.9)
Type of insulin pump
MiniMed Paradigm® Veo™ (Medtronic®)
43 (84.3)
MiniMed 640G - Enlite™ Sensor (Medtronic®)
8 (15.7)
Reported as : standard deviation. Reported as median value (interquartile range); (%): number (percentage); BMI: body mass index; IU: international units; HbA1c: glycosylated hemoglobin. Socioeconomic stratum based on the socioeconomic distribution of households per neighborhood in Colombia.
